CNST News and Press, Constellation Pharmaceuticals Inc. From 01/07/21

Constellation Pharmaceuticals ([[CNST]] +5.4%) appoints Brendan Delaney to the newly created position of Chief Commercial Officer, effective January 11, 2021. In this role, Mr. Delaney will be responsible for building and leading the company’s commercial organizatio...

CAMBRIDGE, Mass., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc. (Nasdaq: CNST) today announced the appointment of Brendan Delaney to the newly created position of Chief Commercial Officer, effective January 11, 2021. In this role, Mr. Delaney will be responsible for ...

Gainers: Obalon Therapeutics (OBLN) +121%.Greenland Technologies (GTEC) +79%.Oncternal Therapeutics (ONCT) +61%.Eastman Kodak (KODK) +60%.Fate Therapeutics (FATE) +46%.Nkarta (NKTX) +44%.Constellation Pharmaceuticals (CNST) +34%.Gamida Cell (GMDA) +31%.EHang Holdings (EH) +30%.Tonix...

Gainers: Obalon Therapeutics (OBLN) +116%, Oncternal Therapeutics (ONCT) +77%, Fate Therapeutics (FATE) +41%, Constellation Pharmaceuticals (CNST) +33%, Nkarta (NKTX) +28%.Losers: scPharmaceuticals (SCPH) -33%, Aptose Biosciences (APTO) -...

Source: Press release"We are pleased both with the response rates and consistency of the results we are seeing in MANIFEST,"says Constellation Pharmaceuticals (CNST) CEO Jigar Raythatha. "In addition, we are excited by results from our translational studies that suggest that CPI-0610 may...

67% spleen volume response rate observed in 63 first-line myelofibrosis patients treated with CPI-0610 + ruxolitinib at 24 weeks CPI-0610 demonst rated activity , both as a monotherapy and as add on to ruxolitinib , in seco...

CAMBRIDGE, Mass., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals , Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, will host a virtual analyst/investor eve...

Company printed above expectation earnings and revenues in latest quarter, mirroring increases in Canada. Company has a new CEO that has 30 years of branding experience and will help to advance the company's goals. The new Israel medical products are selling well and a new partner...

Image source: The Motley Fool. Constellation Pharmaceuticals (NASDAQ: CNST) Q3 2020 Earnings Call Oct 29, 2020 , 8:00 a.m. ET Operator Continue reading For further details see: Constellation Pharmaceuticals (CNST) Q3 2020 Earnings Call Tr...

Gainers: Universal Security Instruments (UUU) +69%.Polar Power (POLA) +37%.Rekor Systems (REKR) +35%.Entercom Communications (ETM) +33%.Pinterest (PINS) +29%.Inphi (IPHI) +28%.Forte Biosciences (FBRX) +21%.Meta Financial Group (CASH) +19%.Novus Therapeutics (NVUS) +18%.Dig...